Wealth Alliance
VRTX icon

Wealth Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History

Wealth Alliance’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$560K Sell
1,071
-355
-25% -$182K 0.04% 287
2026
Q2 		$708K Sell
1,426
-120
-8% -$53.2K 0.06% 243
2026
Q1 		$690K Sell
1,546
-19
-1% -$8.86K 0.07% 240
2025
Q4 		$710K Buy
1,565
+306
+24% +$132K 0.07% 240
2025
Q3 		$493K Buy
+1,259
New +$526K 0.05% 306
2024
Q1 		– Sell
-526
Closed -$214K – 539
2023
Q4 		$214K Buy
+526
New +$194K 0.03% 469

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Wealth Alliance's VRTX Position: Q3 2026 in Review

Wealth Alliance reduced its Vertex Pharmaceuticals (VRTX) stake by 25% in Q3 2026, selling an estimated $182K and leaving 1,071 shares worth $560K. The position accounts for 0.04% of the portfolio, ranked #287.

Wealth Alliance first reported a position in VRTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $710K in Q4 2025. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Wealth Alliance held 1,071 shares of Vertex Pharmaceuticals worth $560K as of Q3 2026.
  • Wealth Alliance sold 355 Vertex Pharmaceuticals shares in Q3 2026, an estimated $182K.
  • Vertex Pharmaceuticals made up 0.04% of Wealth Alliance's portfolio in Q3 2026, its #287 holding.
  • Wealth Alliance first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Wealth Alliance's Vertex Pharmaceuticals position peaked at $710K in Q4 2025.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Wealth Alliance's 13F filing for Q3 2026, filed 13 Nov 2026.